Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
53 hedge funds and large institutions have $69.6M invested in Derma Sciences, Inc. Common Stock (DE) in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 8 closing their positions.
20% more capital invested
Capital invested by funds: $57.8M → $69.6M (+$11.8M)
4% less funds holding
Funds holding: 55 → 53 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$353K |
| 2 |
Renaissance Technologies
New York
|
+$142K |
| 3 |
CMBA
C.M. Bidwell & Associates
Honolulu,
Hawaii
|
+$85.4K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$53.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.09M |
| 2 |
SM
Senvest Management
New York
|
-$977K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$839K |
| 4 |
UBS AM
Chicago,
Illinois
|
-$533K |
| 5 |
RAM
Roanoke Asset Management
Jersey City,
New Jersey
|
-$386K |
DSCI Hedge Fund Activity: Q2 2016 in Review
53 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2016, worth a combined $69.6M — up 20% from $57.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of DSCI and 7 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 11 added.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $353K. The largest seller was Adage Capital Partners, cutting an estimated $1.09M.
- 53 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2016, down from 55 in Q1 2016.
- Funds reported $69.6M of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2016, up 20% quarter-over-quarter.
- 7 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2016 and 8 closed out, a net change of -1 holder.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q2 2016 was Manulife (Manufacturers Life Insurance), an estimated $353K added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q2 2016 was Adage Capital Partners, an estimated $1.09M sold.
Based on aggregated 13F filings for Q2 2016.